Non-cardiac surgery in patients with coronary stents: The RECO study

Heart

Volumn 97, Issue 19, 2011, Pages 1566-1572

  Albaladejo, Pierre ^a,b   Marret, Emmanuel ^c   Samama, Charles Marc ^d   Collet, Jean Philippe ^e   Abhay, Kou ^f   Loutrel, Olivier ^g   Charbonneau, Hélène ^a   Jaber, Samir ^h   Thoret, Sophie ^b   Bosson, Jean Luc ^b   Piriou, Vincent ⁱ  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b LABORATOIRE TIMC IMAG   (France)

^c HÔPITAL TENON   (France)

^d HÔTEL DIEU   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g NANTES UNIVERSITY HOSPITAL   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ Pierre Wertheimer Neurological Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; HEMOGLOBIN;

ABDOMINAL SURGERY; AGED; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CORONARY STENT; CREATININE CLEARANCE; DRUG ELUTING STENT; EMERGENCY SURGERY; FEMALE; GASTROINTESTINAL SURGERY; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONCARDIAC SURGERY; OBSERVATIONAL STUDY; ORTHOPEDIC SURGERY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STENT THROMBOSIS; SURGERY; SURGICAL MORTALITY; THORAX SURGERY; UROLOGIC SURGERY; VASCULAR SURGERY;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; SURGICAL PROCEDURES, OPERATIVE; THROMBOSIS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052662746     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.224519     Document Type: Article

References (32)

1. Nuttall GA, Brown MJ, Stombaugh JW, et al. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008;109:588-95.
2. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008;109:596-604.
3. Muckie M, Khattar RS, Fraser D. Non cardiac surgery and antiplatelet therapy following coronary artery stenting. Heart 2009;95:1303-8.
4. Möllman H, Nef HM, Hamm CW. Clinical pharmacology: antiplatelet therapy during surgery. Heart 2010;96:986-91.
5. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):299S-339S. (Pubitemid 351894915)
6. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74. (Pubitemid 44729867)
7. Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral anti-platelet therapy. Eur Heart J 2006;8(Suppl G):G46-52. (Pubitemid 44526986)
8. Riddell JW, Chiche L, Plaud B, et al. Coronary stents and noncardiac surgery. Circulation 2007;116:e378-82. (Pubitemid 350287111)
9. Collet JP, Aout M, Alantar A, et al. Real-life management of dual antiplatelet therapy interruption: the REGINA survey. Arch Cardiovasc Dis 2009;102:697-710.
10. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9. (Pubitemid 40186800)
11. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-94. (Pubitemid 30206904)
12. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
13. Albaladejo P, Marret E, Piriou V, et al; for the French Society of Anesthesiology and Intensive Care. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force. Br J Anaesth 2006;97:580-2. (Pubitemid 44419977)
14. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. (Pubitemid 29416229)
15. Thygesen K, Alpert JS, White HD; on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. (Pubitemid 350182388)
16. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
17. Schulman S, Kearon C; for the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005;3:692-4. (Pubitemid 41647882)
18. Ward HB, Kelly RF, Thottapurathu L, et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 2006;82:795-800.
19. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795-804. (Pubitemid 40051903)
20. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-7. (Pubitemid 39407340)
21. Beving H, Zhao C, Alba° ge A, et al. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996;7:80-4. (Pubitemid 26106173)
22. Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 2001;94:74-8. (Pubitemid 32055180)
23. Mylotte D, Peace AJ, Tedesco AT, et al. Clopidogrel discontinuation and platelet reactivity following coronary stenting. J Thromb Haemost 2011;9:24-32.
24. Hochholzer W, Trenk D, Fromm MF, et al. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. J Am Coll Cardiol 2010;55:2427-34.
25. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007;297:2481-8. (Pubitemid 46953401)
26. Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008;117:478-84.
27. Reinecke H, Trey T, Wellmann J, et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 2003;24:2142-50. (Pubitemid 37486534)
28. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-9. (Pubitemid 40577898)
29. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003;92:930-5. (Pubitemid 37214804)
30. Silvain J, Pena A, Cayla G, et al. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010;31:2816-21.
31. Anon. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348:1329-39.
32. Samama CM, Bonnin P, Bonneau M. Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig. Thromb Haemost 1992;68:500-5.